Literature DB >> 6198458

Studies on kynurenine in human cerebrospinal fluid: lowered levels in epilepsy.

S N Young, M H Joseph, S Gauthier.   

Abstract

Kynurenine, tryptophan and 5-hydroxyindoleacetic acid were measured in human lumbar and cisternal cerebrospinal fluid (CSF) taken during pneumoencephalography. The results do not support the hypothesis that any substantial part of the CSF kynurenine is of central origin. However, the results suggest that CSF kynurenine is reduced in some epileptic subjects and this seems to be due to the disease rather than anticonvulsants. This finding is of interest in view of the reported convulsant effect of kynurenine in experimental animals.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6198458     DOI: 10.1007/bf01252805

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  26 in total

1.  CSF amino acids and plasma--CSF amino acid ratios in adults.

Authors:  T L Perry; S Hansen; J Kennedy
Journal:  J Neurochem       Date:  1975-03       Impact factor: 5.372

2.  Relationships between tryptophan in serum and CSF, and 5-hydroxyindoleacetic acid in CSF of man: effect of cirrhosis of liver and probenecid administration.

Authors:  S N Young; S Lal; T L Sourkes; F Feldmuller; A Aronoff; J B Martin
Journal:  J Neurol Neurosurg Psychiatry       Date:  1975-04       Impact factor: 10.154

3.  Cerebral tryptophan-2,3-dioxygenase (pyrrolase) and its induction in rat brain.

Authors:  E M Gál
Journal:  J Neurochem       Date:  1974-05       Impact factor: 5.372

4.  The effect of hormones and vitamin B6 on urinary excretion of metabolites of the kynurenine pathway.

Authors:  H Wolf
Journal:  Scand J Clin Lab Invest Suppl       Date:  1974

Review 5.  Monoamine metabolites in lumbar CSF: the question of their origin in relation to clinical studies.

Authors:  E Garelis; S N Young; S Lal; T L Sourkes
Journal:  Brain Res       Date:  1974-10-11       Impact factor: 3.252

6.  The effect of tryptophan metabolites on brain 5-hydroxytryptamine metabolism.

Authors:  A R Green; G Curzon
Journal:  Biochem Pharmacol       Date:  1970-06       Impact factor: 5.858

7.  Interaction of kynurenine and its metabolites with tryptamine, serotonin and its precursors and oxotremorine.

Authors:  I P Lapin
Journal:  Psychopharmacologia       Date:  1972

8.  Kynurenine: penetration to the brain, effect on brain tryptophan and 5-hydroxytryptamine metabolism and binding to plasma albumin [proceedings].

Authors:  M H Joseph; B V Kadam
Journal:  Br J Pharmacol       Date:  1979-07       Impact factor: 8.739

9.  Quinolinic acid: a potent endogenous excitant at amino acid receptors in CNS.

Authors:  T W Stone; M N Perkins
Journal:  Eur J Pharmacol       Date:  1981-07-10       Impact factor: 4.432

10.  Liquid chromatographic-fluorometric system for the determination of indoles in physiological samples.

Authors:  G M Anderson; W C Purdy
Journal:  Anal Chem       Date:  1979-02       Impact factor: 6.986

View more
  2 in total

1.  Kynurenine pathway metabolites in humans: disease and healthy States.

Authors:  Yiquan Chen; Gilles J Guillemin
Journal:  Int J Tryptophan Res       Date:  2009-01-08

2.  Effect of quinolinic acid on wakefulness and sleep in the rabbit.

Authors:  A M Milaśius; K K Grinevićius; I P Lapin
Journal:  J Neural Transm Gen Sect       Date:  1990
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.